Blue Owl Capital Holdings LP

Holdings History for ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Symbol: ADCT on NYSE
Investment type: Equity / Common Shares, par value CHF 0.08 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.91%	0%	$2,934,272	733,568	0		$4.00	Q4 2025
30 Sep 2025	0.91%	0%	$2,934,272	733,568	0		$4.00	Q3 2025
30 Jun 2025	0.63%	0%	$1,965,962	733,568	0		$2.68	Q2 2025
31 Mar 2025	0.33%	0%	$1,034,331	733,568	0		$1.41	Q1 2025
31 Dec 2024	0.35%	0%	$1,459,800	733,568	0		$1.99	Q4 2024
30 Sep 2024	0.45%	0%	$2,310,739	733,568	0		$3.15	Q3 2024
30 Jun 2024	0.65%	0%	$2,318,075	733,568	0		$3.16	Q2 2024
31 Mar 2024	0.74%	0%	$3,293,720	733,568	0		$4.49	Q1 2024
31 Dec 2023	0.3%	0%	$1,217,723	733,568	0		$1.66	Q4 2023
30 Sep 2023	0.51%	0%	$654,489	733,568	0		$0.89	Q3 2023
30 Jun 2023	0.97%	0%	$1,577,171	733,568	0		$2.15	Q2 2023
31 Mar 2023	0.93%	0%	$1,430,458	733,568	0		$1.95	Q1 2023
31 Dec 2022	1.2%	0%	$2,816,901	733,568	0		$3.84	Q4 2022
30 Sep 2022	1.5%	+1.5%	$3,536,000	733,568	+733,568	NEW	$4.82	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.